On October 29, 2024, the World Health Organization (WHO) published its Global TB Report 2024. India has made amazing strides in reducing the number of undetected TB infections since 2015, according to the research. An estimated 27 lakh TB cases were reported in India in 2023, of which 25.1 lakh people received a diagnosis and began treatment. This has helped close the gap of missing cases by increasing India's treatment coverage from 72% in 2015 to 89% in 2023.
According to the WHO, India's TB incidence decreased from 237 cases per lakh population in 2015 to 195 cases per lakh population in 2023, representing a 17.7% decline. This is more than twice as fast as the global decline of 8.3%. This increase in coverage is the consequence of India's efforts to decentralize healthcare services through more than 1.7 lakh cases, as well as the momentum the country has built and maintained around TB case discovery.
Although the WHO reduced its estimate of TB mortality in India last year, the new study shows that India has consistently reduced the number of TB-related deaths from 28 per lakh to 22 per lakh, a 21.4% decrease.
According to the WHO study, government funds provide for the majority of the TB program's funding. Modern molecular diagnostic tools have been scaled up in India throughout the years, along with improved and more effective treatment regimens and free screening, diagnosis, and treatment for all TB patients. With a share of 32.9% of all cases in 2023, the private sector has made a substantial contribution to this endeavor. In addition to India's vast TB laboratory network, which is the largest in the world with 7,767 quick molecular testing facilities and 87 culture & drug susceptibility testing laboratories dispersed throughout the nation, the government is acquiring more than 800 AI-enabled portable chest x-ray devices.
0 Comments